Medy-Tox Inc. (KOSDAQ:086900)
144,100
-2,500 (-1.71%)
Aug 8, 2025, 3:30 PM KST
SolarWinds Market Cap
Medy-Tox has a market cap or net worth of 1.03 trillion as of August 8, 2025. Its market cap has decreased by -2.36% in one year.
Market Cap
1.03T
Enterprise Value
1.05T
Revenue
237.99B
Ranking
n/a
PE Ratio
54.76
Stock Price
$144,100.00
Market Cap Chart
Since January 16, 2009, Medy-Tox's market cap has increased from 71.73B to 1.03T, an increase of 1,334.70%. That is a compound annual growth rate of 17.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 7, 2025 | 1,029.04B | 23.82% |
Dec 30, 2024 | 831.10B | -48.75% |
Dec 28, 2023 | 1,621.72B | 101.16% |
Dec 29, 2022 | 806.18B | -7.99% |
Dec 30, 2021 | 876.20B | -13.91% |
Dec 30, 2020 | 1,017.74B | -39.32% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 74.80T |
Celltrion | 39.20T |
ALTEOGEN | 23.73T |
SK Biopharmaceuticals | 8,724.10B |
Yuhan | 8,599.10B |
Peptron | 6,872.72B |
HLB Co., Ltd. | 6,237.58B |
PharmaResearch | 5,859.76B |